Hubei International Scientific and Technological Cooperation Base of Traditional Fermented Foods, Key Laboratory of Environment Correlative Dietology, College of Food Science and Technology, Huazhong Agricultural University, Wuhan, Hubei Province 430070, China.
Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, Tongji Medical College, Huazhong University of Science and Technology, Hangkong Road 13, Wuhan 430030, China.
J Agric Food Chem. 2024 Jan 17;72(2):1114-1123. doi: 10.1021/acs.jafc.3c08187. Epub 2024 Jan 3.
Natural products are a rich resource for the discovery of innovative drugs. Microbial cocultivation enables discovery of novel natural products through tandem enzymatic catalysis between different fungi. In this study, , as a food fermentation strain capable of producing abundant natural products, was chosen as an example of a cocultivation pair strain. Cocultivation screening revealed that and led to the production of two novel cyclohexyl-furans, Monaspins A and B. Optimization of the cocultivation mode and media enhanced the production of Monaspins A and B to 1.2 and 0.8 mg/L, respectively. Monaspins A and B were structurally elucidated by HR-ESI-MS and NMR. Furthermore, Monaspin B displayed potent antiproliferative activity against the leukemic HL-60 cell line by inducing apoptosis, with a half-maximal inhibitory concentration (IC) of 160 nM. Moreover, in a mouse leukemia model, Monaspin B exhibited a promising in vivo antileukemic effect by reducing white blood cell, lymphocyte, and neutrophil counts. Collectively, these results indicate that Monaspin B is a promising candidate agent for leukemia therapy.
天然产物是发现创新药物的丰富资源。微生物共培养通过不同真菌之间的串联酶催化作用,能够发现新型天然产物。在这项研究中,作为一种能够产生丰富天然产物的食品发酵菌株,被选为共培养对菌株的一个例子。共培养筛选显示, 和 导致两种新型环己基呋喃,单孢菌素 A 和 B 的产生。通过优化共培养模式和培养基,将单孢菌素 A 和 B 的产量分别提高到 1.2 和 0.8 mg/L。通过高分辨电喷雾质谱(HR-ESI-MS)和 NMR 对单孢菌素 A 和 B 的结构进行了阐明。此外,单孢菌素 B 通过诱导细胞凋亡,对白血病 HL-60 细胞系显示出很强的增殖抑制活性,半数最大抑制浓度(IC)为 160 nM。此外,在小鼠白血病模型中,单孢菌素 B 通过降低白细胞、淋巴细胞和中性粒细胞计数,表现出有希望的体内抗白血病作用。总之,这些结果表明单孢菌素 B 是一种有前途的白血病治疗候选药物。